Comments on the CFDA's "Provisions on Monitoring of Adverse Events and Re-evaluation of Medical Devices"

2016-12-05 | Beijing

The Healthcare Equipment Working Group submitted consolidated comments on the CFDA's draft "Provisions on Monitoring of Adverse Events and Re-evaluation of Medical Devices".

The Working group submitted a total of 38 comments to the draft provisions with the target to make the provisions more practical for the industry, e.g. to allow a longer period for report adverse events encountered abroad to the Chinese authorities.

More information: http://www.cfda.gov.cn/WS01/CL0779/165701.html